Non-contrast, ventilation-perfusion imaging-from routine chest CT scansMELBOURNE, Australia, June 29, 2026 /PRNewswire/ -- 4DMedical Limited (ASX: 4DX), the global leader in advanced respiratory ...
CT:VQ™ gives physicians access to ventilation and perfusion imaging and data derived directly from routine, non-contrast, chest CT scans. CT:VQ™ delivers regional functional l ...
Favourable safety profile in marked contrast to traditional inotropic therapeuticsAC01 showed rapid and sustained numerical improvements in cardiac output, structure and functionSTOCKHOLM, Sweden, ...
In Brazil, a 22-year-old lawyer has died during a routine examination. Leticia Paul went into anaphylactic shock shortly ...
AWS has introduced Lambda MicroVMs, built on its Firecracker virtual machine monitor, which can run isolated Linux containers ...
The FDA has approved Ambelvist, a macrocyclic gadolinium-based option for contrast-enhanced MRI, now the lowest ...
India’s rapidly growing 5G adoption based on enhanced mobile broadband and 5G FWA is transforming consumer experiences,” notes Nitin Bansal, Managing Director, Ericsson India. And that takes me to a ...
The insurer is cutting pay and benefits while requiring agents to adopt new AI tools, after losing its top auto insurer ...
The FDA has approved Bayer’s Ambelvist (gadoquatrane), the lowest-dose macrocyclic GBCA for adult and pediatric contrast-enhanced CNS and body MRI exams.
The approval is based on global Phase III QUANTI studies evaluating Ambelvist's efficacy and safety in adults and children.
By merging transactional and analytical workloads, LTAP promises fewer pipelines, lower costs, and better governance.
The FDA has cleared several oncology products over the past few days, ranging from therapies to diagnostic and imaging tools.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results